Next-generation, personalised, model-based critical care medicine: a state-of-the art review of in silico virtual patient models, methods, and cohorts, and how to …

JG Chase, JC Preiser, JL Dickson, A Pironet… - Biomedical engineering …, 2018 - Springer
Critical care, like many healthcare areas, is under a dual assault from significantly
increasing demographic and economic pressures. Intensive care unit (ICU) patients are …

Glucose control in the ICU: a continuing story

JC Preiser, JG Chase, R Hovorka… - Journal of diabetes …, 2016 - journals.sagepub.com
In the present era of near-continuous glucose monitoring (CGM) and automated therapeutic
closed-loop systems, measures of accuracy and of quality of glucose control need to be …

Generalisability of a virtual trials method for glycaemic control in intensive care

JL Dickson, KW Stewart, CG Pretty… - IEEE transactions on …, 2017 - ieeexplore.ieee.org
Background: Elevated blood glucose (BG) concentrations (Hyperglycaemia) are a common
complication in critically ill patients. Insulin therapy is commonly used to treat …

Untangling glycaemia and mortality in critical care

V Uyttendaele, JL Dickson, GM Shaw, T Desaive… - Critical Care, 2017 - Springer
Background Hyperglycaemia is associated with adverse outcomes in the intensive care unit,
and initial studies suggested outcome benefits of glycaemic control (GC). However …

[HTML][HTML] Percentage of time in range 70 to 139 mg/dL is associated with reduced mortality among critically ill patients receiving IV insulin infusion

MJ Lanspa, JS Krinsley, AM Hersh, EL Wilson… - Chest, 2019 - Elsevier
Background In addition to hyperglycemia, hypoglycemia, and glycemic variability, reduced
time in targeted blood glucose range (TIR) is associated with increased risk of death in …

Glycemic control in the intensive care unit: a control systems perspective

JG Chase, B Benyo, T Desaive - Annual Reviews in Control, 2019 - Elsevier
Computers and automation have revolutionised quality and productivity in many industries,
but not in medicine. Healthcare costs are thus growing beyond the ability of society to pay for …

Improving glycemic control in critically ill patients: personalized care to mimic the endocrine pancreas

JG Chase, T Desaive, J Bohe, M Cnop, C De Block… - Critical Care, 2018 - Springer
There is considerable physiological and clinical evidence of harm and increased risk of
death associated with dysglycemia in critical care. However, glycemic control (GC) currently …

Clinical effectiveness of intravenous exenatide infusion in perioperative glycemic control after coronary artery bypass graft surgery

G Besch, A Perrotti, F Mauny, M Puyraveau… - …, 2017 - ingentaconnect.com
Background: We aimed to assess the clinical effectiveness of intravenous exenatide
compared to insulin in perioperative blood glucose control in coronary artery bypass grafting …

A 3D insulin sensitivity prediction model enables more patient-specific prediction and model-based glycaemic control

V Uyttendaele, JL Knopp, KW Stewart… - … Signal Processing and …, 2018 - Elsevier
Background Insulin therapy for glycaemic control (GC) in critically ill patients may improve
outcomes by reducing hyperglycaemia and glycaemic variability, which are both associated …

3D kernel-density stochastic model for more personalized glycaemic control: development and in-silico validation

V Uyttendaele, JL Knopp, S Davidson… - Biomedical engineering …, 2019 - Springer
Background The challenges of glycaemic control in critically ill patients have been debated
for 20 years. While glycaemic control shows benefits inter-and intra-patient metabolic …